Presentation TCT Abstracts Posters 2018 Cost-Consequence Analysis of Cangrelor Use in High Angiographic Risk Percutaneous Coronary Intervention (PCI) Patients: A US Hospital Perspective Presenter: Ivar S Jensen September 25, 2018
Presentation TCT 2018 Utility of Cangrelor During PCI and Bridging Who Benefits Most? Presenter: John A. Bittl, C. Michael Gibson, Deepak L. Bhatt September 23, 2018
News Conference News ESC 2018 New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All Michael O'Riordan August 29, 2018
News Conference News ESC 2018 Pretreatment With P2Y12 Inhibitors Questioned Anew in SCAAR Shelley Wood August 28, 2018
News Daily News Women Underrepresented in Pivotal Studies Leading to FDA Drug Approval Michael O'Riordan May 01, 2018
Presentation JIM 2018 Cangrelor is ready for prime time Presenter: Dominick J. Angiolillo February 23, 2018